Dr. Martin E Gleave, MD

Claim this profile

Vancouver Prostate Centre

Studies Prostate Cancer
1 reported clinical trial
6 drugs studied

Affiliated Hospitals

Image of trial facility.
Vancouver Prostate Centre

Clinical Trials Martin E Gleave, MD is currently running

Image of trial facility.

Genomic Biomarker-Selected Therapy

for Prostate Cancer

The objective of this study is to see if providing an appropriate therapy based on the genomic testing of prostate tumour tissue will result in an improved clinical response. Each participant will be treated with 8 weeks of a luteinizing hormone-releasing hormone agonist (LHRHa) plus apalutamide (APA) while genome sequence characterization is being done. Participants with biopsy specimens deemed unevaluable for genomic testing will remain on LHRHa plus APA for an additional 16 weeks. Participants with evaluable tissue will be assigned to one of the open-label sub-studies on the basis of genomic profiling results. Within each group, they will be randomized to a specific treatment arm either LHRHa plus APA alone or adding abiraterone acetate and prednisone, docetaxel or niraparib. The study will evaluate the response rate and outcomes after radical prostatectomy in each arm of the trial.
Recruiting1 award Phase 210 criteria

More about Martin E Gleave, MD

Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Martin E Gleave, MD has experience with
  • Abiraterone Acetate 250mg
  • Apalutamide
  • Docetaxel
  • Luteinizing Hormone-releasing Hormone Agonist (LHRHa)
  • Niraparib 100mg Oral Capsule
  • Prednisone 5mg Tab
Breakdown of trials Martin E Gleave, MD has run
Prostate Cancer

Other Doctors you might be interested in

Peter Black, MDVancouver Prostate Centre
Ryan Flannigan, MDVancouver Prostate Centre

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Martin E Gleave, MD specialize in?
Martin E Gleave, MD focuses on Prostate Cancer and other conditions. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Martin E Gleave, MD currently recruiting for clinical trials?
Yes, Martin E Gleave, MD is currently recruiting for 1 clinical trial in Vancouver British Columbia. If you're interested in participating, you should apply.
Are there any treatments that Martin E Gleave, MD has studied deeply?
Yes, Martin E Gleave, MD has studied treatments such as Abiraterone Acetate 250mg, Apalutamide, Docetaxel.
What is the best way to schedule an appointment with Martin E Gleave, MD?
Apply for one of the trials that Martin E Gleave, MD is conducting.
What is the office address of Martin E Gleave, MD?
The office of Martin E Gleave, MD is located at: Vancouver Prostate Centre, Vancouver, British Columbia V5Z 1M9 Canada. This is the address for their practice at the Vancouver Prostate Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top